A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER

被引：0
|
作者：
Goh, T. H. [1 ]
Tan, S. C. [1 ]
Fook-Chong, S. M. C. [1 ]
Wong, K. S. [1 ]
Chan, C. M. [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [1] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [2] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [3] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [4] Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation A Nationwide Cohort Study
    Hsieh, Yu-Cheng
    Hung, Chen-Ying
    Li, Cheng-Hung
    Liao, Ying-Chieh
    Huang, Jin-Long
    Lin, Ching-Heng
    Wu, Tsu-Juey
    MEDICINE, 2016, 95 (20)
  • [5] Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?
    Berns, Jeffrey S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 192 - 196
  • [6] Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    Carson, PE
    AMERICAN HEART JOURNAL, 2000, 140 (03) : 361 - 366
  • [7] Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin h receptor blocker therapy in heart failure
    Yasumura, Y
    Miyatake, K
    Okamoto, H
    Miyauchi, T
    Kawana, M
    Tsutamoto, T
    Kitakaze, M
    Matsubara, H
    Takaoka, H
    Anzai, T
    Himeno, H
    Yokoyama, H
    Yokoya, K
    Shintani, U
    Hashimoto, K
    Koretsune, Y
    Nakamura, Y
    Imai, K
    Maruyama, S
    Masaoka, Y
    Sekiya, M
    Shiraki, T
    Shinohara, H
    Ozono, K
    Matsuoka, T
    Miyao, Y
    Nomura, F
    CIRCULATION JOURNAL, 2004, 68 (04) : 361 - 366
  • [8] Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease
    Abe, Daisuke
    Sato, Akira
    Misaki, Masako
    Takeyasu, Noriyuki
    Hoshi, Tomoya
    Aonuma, Kazutaka
    CIRCULATION, 2013, 128 (22)
  • [9] Re: Is there a difference in the effect between the angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker on the COVID-19?
    Liu, Xiao
    Long, Chuyan
    Xiong, Qinmei
    Chen, Chen
    Ma, Jianyong
    Su, Yuhao
    Hong, Kui
    CLINICAL CARDIOLOGY, 2021, 44 (01) : 7 - 8
  • [10] Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions
    Carlson, Geoffrey S.
    Wong, Priscilla H.
    White, Kevin M.
    Quinn, James M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05): : 1430 - 1432
12345